Dynamic inflammation-based prognostication in acute-on-chronic liver failure: The COSSH-CAR model as a step forward in personalized risk stratification
Open Access
- 27 February 2026
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 18 (2) , 113552
Abstract
Acute-on-chronic liver failure (ACLF) is a swiftly deteriorating condition characterized by profound systemic inflammation and failure of multiple organ systems, leading to high early mortality. There remains a critical need for more effective biomarkers to facilitate timely and accurate risk assessment. Recent findings by Zhu and Yan demonstrated that evaluating temporal changes in the C-reactive protein to albumin ratio (CAR), especially the 7-day variation, offers superior prediction of 28-day mortality compared with single baseline measurements. By integrating the 7-day variation of CAR with the model for end-stage liver disease sodium score and the grade of hepatic encephalopathy, the Chinese Group on Study of Severe Hepatitis B (COSSH)-CAR model was created, which surpassed traditional prognostic tools such as the Child-Pugh, model for end-stage liver disease, and COSSH-ACLF. This comment highlights the importance of using dynamic biomarker trajectories rather than static values for prognostic evaluation. CAR is biologically compelling because it captures both the inflammatory burden and the patient’s nutritional/physiological reserve. While the COSSH-CAR model is promising and based on routinely obtainable laboratory data, its widespread adoption will depend on validation in larger, diverse, and non-hepatitis B virus-related cohorts. Future work should examine CAR kinetics in prospective and interventional studies and consider how they may support individualized management strategies. Collectively, these observations suggest that the CAR could represent an important addition to current ACLF prognostic frameworks.Keywords
This publication has 26 references indexed in Scilit:
- Association between neutrophil percentage to albumin ratio and short term prognosis of acute on chronic liver failure treated with artificial liver support systemScientific Reports, 2025
- Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learningDigestive and Liver Disease, 2024
- Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosisScientific Reports, 2023
- C-reactive protein-to-albumin ratio as a biomarker in patients with sepsis: a novel LASSO-COX based prognostic nomogramScientific Reports, 2023
- Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomesJournal of Hepatology, 2023
- EASL Clinical Practice Guidelines on acute-on-chronic liver failureJournal of Hepatology, 2023
- Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failureJHEP Reports, 2023
- PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJournal of Hepatology, 2021
- A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicatorsScientific Reports, 2021
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)Hepatology International, 2008